Montag & Associates’s DaVita DVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-4,830
Closed -$313K 250
2017
Q2
$313K Sell
4,830
-57,751
-92% -$3.82M 0.04% 211
2017
Q1
$4.25M Buy
+62,581
New +$4.14M 0.48% 60
2015
Q1
Sell
-26,765
Closed -$2.03M 254
2014
Q4
$2.03M Hold
26,765
0.3% 104
2014
Q3
$1.96M Sell
26,765
-810
-3% -$59.3K 0.32% 96
2014
Q2
$1.99M Sell
27,575
-3,020
-10% -$210K 0.33% 101
2014
Q1
$2.11M Sell
30,595
-13,875
-31% -$922K 0.36% 96
2013
Q4
$2.82M Sell
44,470
-2,410
-5% -$141K 0.48% 71
2013
Q3
$2.67M Buy
46,880
+14,210
+43% +$814K 0.5% 68
2013
Q2
$1.97M Buy
+32,670
New +$2.04M 0.4% 84

Other funds holding DVA

Montag & Associates's DVA Position: Q3 2017 in Review

Montag & Associates sold out of DaVita (DVA) in Q3 2017, closing a stake of 4,830 shares — an estimated $313K sold.

Montag & Associates first reported a position in DVA in Q2 2013 and held it in 9 quarters. The position peaked at $4.25M in Q1 2017. 443 funds tracked by Wall St. Rank hold DVA as of Q3 2017.

  • Montag & Associates reported no remaining DaVita position as of Q3 2017 after selling out during the quarter.
  • Montag & Associates sold 4,830 DaVita shares in Q3 2017, an estimated $313K.
  • Montag & Associates first reported a position in DaVita in Q2 2013 and held it in 9 quarters.
  • Montag & Associates's DaVita position peaked at $4.25M in Q1 2017.
  • 443 funds tracked by Wall St. Rank held DaVita as of Q3 2017.

Based on Montag & Associates's 13F filing for Q3 2017, filed 6 Nov 2017.